Connect with us


CBD Treatment for Social Anxiety



If we were to rank the degree to which CBD has been accepted and adopted by society at large as a device for therapy and treatment of various different types of health concerns and conditions, we might rank its application for anxiety, and particularly social anxiety, as very near the top.

One of the reasons for this is because the available treatments can be seen as falling so far short, as well as containing of vast array of different unwanted side effects.

In addition, social anxiety is very difficult to define from a medical standpoint in terms of causality. And therefore, the scientists that sit in the pantheon for the medical and pharmaceutical establishment have a very difficult time understanding how to come up with a large or small molecule treatment.

In some sense, this makes it seem as if social anxiety is not a “real” treatable condition. But for those suffering from this condition, that isn’t very reassuring. That’s why many people are now embracing CBD as a very important part of this equation. So let’s explore the specifics of that development.

Understanding Social Anxiety

The acronym providing the shorthand for social anxiety disorder is one of the most appropriate acronyms that we have in the English language: SAD.

Social anxiety disorder, or “social phobia”, is really about the avoidance of complex or significant social situations. Think of it something like a fear of being in the spotlight of the perception of other people, particularly in group situations.

It is thought that this condition could affect as many as 1% of the current population of the United States. But it is important to not confuse this with concepts such as a fear of public speaking or “stage fright”, which are vastly more common.

In this case, we are focused strictly on very nonthreatening social interactions – the simple experience of everyday life among people. And one can imagine how this may have a dramatic impact on one’s ability to actualize themselves in daily life or experience a sense of quality of life.

While only about 3 million Americans statistically suffer from social anxiety disorder, the condition is particularly prevalent in those between the ages of 13 and 18 years of age. And this makes sense: for most of us, we can recall these years and understand exactly what this statistic is pointing to. This is when you’re just beginning to come to understand yourself in the world as a separate being and a part of a larger society. And part of that process of understanding is about what psychologists call the self-reflective mirror. It is about imagining how others are perceiving and judging you.

CBD and Social Anxiety Disorder

Social anxiety disorder is effectively an inflation of the importance of assessing and understanding hypotheses about the perception and judgment of others.

Most importantly, however, the end result of this is a cycle of emotionality that results in something that can be thought of as “learned fear”. This shifts the neurochemistry of an individual into what can progress into a chronic state.

At the end of the day, as we are now beginning to understand, this comes down to the actions of the cannabinoid receptors in the brain. The brain’s primary excitatory neurotransmitter is known as glutamate. It is up to the cannabinoids receptors in the mammalian brain to control the release and reuptake of glutamate.

The principal inhibitor of glutamate is GABA. It is through the regulation of the combination of these two molecules that the endocannabinoid system modulates a homeostasis of the brain that comes into play as a critical element in the equation that drives the existence of this chronic form of social anxiety disorder.

As we have covered extensively, introduction of CBD into the endocannabinoid system leads to a strong potential for a rebalancing of the functionality of that system.

Further research will likely demonstrate the precise specifics of how CBD related products impact the endocannabinoid system’s regulation of these important elements of neurochemistry to control and resolve situations that result in a chronic version of social anxiety disorder

Continue Reading


CannTrust Holdings Inc (NYSE:CTST) Penetrates Into The United States After Investing $20 Million



CannTrust Holdings Inc (NYSE:CTST), a Canadian company that produces and sells medical and recreational marijuana has announced the expansion of its business into the United States.

The Canadian firm revealed that it signed a Letter of Intent through which it will start working with Elk Grove Farming Company, LLC to access more than 3,000 hemp production acres in California. The two companies struck a joint partnership that will allow CannTrust to secure a footing in the California market which is one of the biggest cannabis markets in the U.S.

“This agreement represents another bold move for CannTrust. Our U.S. operation is expected to deliver a significant increase in low-cost production capacity,” stated CannTrust CEO Peter Aceto.

CannTrust is financially ready to tap into the U.S market

The CannTrust CEO also noted that the company will take advantage of its experience in the formulation of standardized CBD products as part of its strategy to enter the U.S market. Mr. Aceto also revealed that his company’s successful equity offering provided enough financial muscle to fuel its ambitious expansion plans.

CannTrust aims to be among the leading and trusted suppliers of high-quality, standardized CBD formulations derived from hemp. The company believes that there will be an increasing demand for high-grade CBD formulations from international retailers. It therefore makes sense to invest in processes that will add value to the end product such as genetic studies and expert growing practices to achieve the highest safety and quality standards.

Elk Grove and CannTrust will each have 50% ownership in their joint operations. Elk Grove is an ideal partner for the endeavor because it has years of farming experience in a variety of products. Its focus includes products designed for crop protection, supply, and input. Its operations are distributed across California, which means that the groundwork has already been laid for the partnership. It will thus be easier for the CannTrust to penetrate into the California market.

Elk Grove executive Morgan Houchin stated that his company was excited about the partnership with CannTrust. He added that his firm’s experience in farming operations will be a great combination with CannTrust’s experience in creating class-leading formulations.

Continue Reading


Rocky Mountain High Brands Inc (OTCMKTS:RMHB) Strikes Broker Deal With Carlin Group



Lifestyle brand management firm Rocky Mountain High Brands Inc (OTCMKTS:RMHB) announced on Wednesday that it secured a broker deal with Carlin Group for its products in the retail space.

The broker agreement will allow Carlin to represent RMHB’s CBD-infused drinks through the HEMPd brand. It will also represent beverages infused with Hempseed extract under RMHB brands. The deal will also cover CBD-infused wellness products such as lotions, water-soluble solutions, capsules, gummies and tinctures as part of the HEMPd brand. Spirit Water will also be covered under the agreement.

The RMHB-Carlin broker deal covers multiple states. They include Missouri, Nebraska, Texas, South Dakota, North Dakota, Minnesota, Wisconsin, Illinois, Pennsylvania, Tennessee, Kentucky, Ohio, Indiana, and Michigan.

“We are very excited about the opportunity to have our entire product line represented by Carlin Group,” stated RMHB CEO Michael Welch.

The Carlin broker deal will boost RMHB’s exposure

Welch noted that the broker deal will strategically allow RMHB to leverage optimal exposure to mass marketers, grocery store chains, convenient stores, major retailers and other types of outlets. The company would not have managed to reach such a wide range of outlets cost-effectively without a broker deal.

The RMHB CEO also added that his company and Carlin will maintain a close collaboration so that they can facilitate retail availability of RMHB products. Welch also revealed that RMHB reviewed numerous other retail introduction options. This was before settling on Carlin which the company believes is the best-suited brand to rapidly get its products onto retail shelves.

Carlin Group’s Managing Director Albert Vergilio noted in a statement that his company was excited to host RMHB and the CBD-based products that are part of its HEMPd brand in Carlin’s new CBD division. He also added that it is part of investing in the future of CBD considering the fast-tracked popularity of CBD products, and the regulations that govern them.

Carlin’s sales team will undergo some training to get them acquainted with RMBH’s products. The sales team will then hold meetings with corporate customers as part of the retail rollout of the products. Sales that will be part of the broker deal are expected to kick off in Q3.

Continue Reading


Wildflower Brands Inc (OTCMKTS:WLDFF) Establishes Footprint Across The US With PO For Hemp CBD Products From Dillard’s Department Stores And Eyes Markets In Texas And Florida



Wildflower Brands Inc (OTCMKTS:WLDFF) has announced establishing a nationwide presence with a PO from Dillard’s Department store. The company has fulfilled the PO received from Dillard.

Hemp CBD products in 292 locations

Dillard’s department store will showcase the premium hemp CBD products of Wildflower in its 292 locations across the US. With its best practices and transparency, Wildflower is eyeing the key markets in Texas and Florida. The company will educate the customers in these regions about salable products. Wildflower has received subsequent orders from Dillard’s and is fulfilling the requirements.

Chief Executive Officer of Wildflower, William Maclean said the supply of CBD infused products to Dillard’s Department stores doubles the existing retail locations in the nation. The company aims to capitalize on its brand to become a household name. It will improve loyalty building because of the reputation and respect of Dillard’s as a retailer. Wildflower aims to provide health and wellness benefits of its CBD infused products to the customers in the US through Dillard’s.

Signs a deal with Highmark Interactive

Wildflower has signed a deal to use EQ – Brain Tracking, mobile software of Highmark Interactive, in the clinical research to study the functional neurological and cognitive effects of CBD. The company aims to get meaningful results and data that help to understand the functional and cognitive neurological properties of the cannabinoids.

William said the company would collect testimonials from the customers on its products that provide the health and wellness needs using plant-based solutions. The company will strive to improve the products, and the research helps it to reach that goal and growth with continued investments.

Acquires City Cannabis Corp

Wildflower has signed an LOI on April 3, 2019, to take over City Cannabis Corp. The company will issue its 60 million common shares for the takeover. The companies will complete the acquisition on receiving advice from corporate, tax, and securities law departments.

The cannabis retailer City Cannabis holds two licenses in the City of Vancouver to market cannabis. It is generating profits through operating dispensaries in Vancouver. The acquisition helps Wildflower to expand retail footprint using the expertise of City Cannabis.

Continue Reading

Trending Stories